Home › Compare › EVOK vs VICI

EVOK vs VICI: Dividend Comparison 2026

EVOK yields 18.18% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $901.0K in total portfolio value· pulled ahead in Year 5
10 years
EVOK
EVOK
● Live price
18.18%
Share price
$11.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$65.3K
Annual income
$5,522.63
Full EVOK calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — EVOK vs VICI

📍 VICI pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEVOKVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EVOK + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EVOK pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVOK
Annual income on $10K today (after 15% tax)
$1,545.45/yr
After 10yr DRIP, annual income (after tax)
$4,694.24/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $511,575.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVOK + VICI for your $10,000?

EVOK: 50%VICI: 50%
100% VICI50/50100% EVOK
Portfolio after 10yr
$515.8K
Annual income
$306,449.38/yr
Blended yield
59.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

EVOK
Analyst Ratings
9
Buy
3
Hold
Consensus: Buy
Price Target
$18.00
+63.6% upside vs current
Range: $18.00 — $18.00
Altman Z
-10.8
Piotroski
3/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVOK buys
0
VICI buys
0
No recent congressional trades found for EVOK or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEVOKVICI
Forward yield18.18% ✓6.52%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$65.3K$966.2K ✓
Annual income after 10y$5,522.63$607,376.13 ✓
Total dividends collected$35.3K$926.2K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$18.00$31.60 ✓

Year-by-year: EVOK vs VICI ($10,000, DRIP)

YearEVOK PortfolioEVOK Income/yrVICI PortfolioVICI Income/yrGap
1$12,518$1,818.18$11,361$941.49+$1.2K → EVOK
2$15,522$2,127.13$13,320$1,481.32+$2.2K → EVOK
3$19,073$2,464.94$16,284$2,405.01+$2.8K → EVOK
4$23,239$2,830.78$21,040$4,071.78+$2.2K → EVOK
5← crossover$28,089$3,223.43$29,209$7,285.49$1.1K → VICI
6$33,697$3,641.30$44,443$14,006.51$10.7K → VICI
7$40,138$4,082.45$75,822$29,512.55$35.7K → VICI
8$47,492$4,544.69$148,733$69,726.75$101.2K → VICI
9$55,842$5,025.61$344,394$189,413.75$288.6K → VICI
10$65,274$5,522.63$966,234$607,376.13$901.0K → VICI

EVOK vs VICI: Complete Analysis 2026

EVOK — Stock

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Full EVOK Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this EVOK vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVOK vs SCHDEVOK vs JEPIEVOK vs OEVOK vs KOEVOK vs MAINEVOK vs NNNEVOK vs EPRTEVOK vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.